Statements (71)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
patent
|
| gptkbp:hasAbstract |
This patent describes a method for treating a specific disease using a novel compound.
|
| gptkbp:hasApplicationNumber |
10/123,456
|
| gptkbp:hasArea |
clinical database.
|
| gptkbp:hasAssignee |
Company XYZ
|
| gptkbp:hasCitedPatent |
US_5,678,901
Journal_of_Medicine,_2003. |
| gptkbp:hasClaim |
20 claims
|
| gptkbp:hasCollaborationsWith |
gptkb:University_of_Science
ABC_Institute. |
| gptkbp:hasCountry |
gptkb:United_States
|
| gptkbp:hasDescription |
The invention relates to a method for treating a disease.
randomized controlled trial. |
| gptkbp:hasEquipment |
treatment of specific cancer.
|
| gptkbp:hasEvents |
ongoing.
|
| gptkbp:hasExaminer |
Jane_Smith
|
| gptkbp:hasFacility |
US,_EP,_JP.
|
| gptkbp:hasFeature |
no serious adverse events.
showed 70% response rate. |
| gptkbp:hasFieldOfUse |
pharmaceuticals
medical treatment |
| gptkbp:hasFilingDate |
2004-02-06
|
| gptkbp:hasFilm |
nausea, headache.
|
| gptkbp:hasFunding |
gptkb:National_Institutes_of_Health
NIH. |
| gptkbp:hasGoals |
Figures 1-5
|
| gptkbp:hasImpactOn |
5.0.
|
| gptkbp:hasInternationalClassification |
A61K
|
| gptkbp:hasInventor |
gptkb:John_Doe
|
| gptkbp:hasLegalStatus |
Active
|
| gptkbp:hasLocalCuisine |
NCT01234567
12 months. Phase II. |
| gptkbp:hasMerchandise |
inhibitor of enzyme X.
|
| gptkbp:hasOccupation |
approved by ethics board.
FDA_approved |
| gptkbp:hasPartnershipsWith |
in progress.
Company DEF. with Company GHI. |
| gptkbp:hasPatentNumber |
6,789,602
|
| gptkbp:hasPerformedAt |
tablet.
|
| gptkbp:hasPersonnel |
Exclusive_License_to_Company_ABC
|
| gptkbp:hasPopulation |
adults.
200 patients. |
| gptkbp:hasPriorityDate |
2004-09-14
2003-02-06 2024-09-14 |
| gptkbp:hasPublications |
2004-09-14.
2004/0123456 A1 |
| gptkbp:hasRecognition |
p<0.05.
|
| gptkbp:hasRelatedPatent |
gptkb:US_6,789,601_C61
new chemical entity. |
| gptkbp:hasResearchInterest |
pharmaceutical research
R01 grant. published_in_Journal_of_Medicine. |
| gptkbp:hasResidence |
XYZ_University.
|
| gptkbp:hasRestrooms |
obtained.
|
| gptkbp:hasSpecialty |
patent pending.
overall survival. submitted_to_FDA. |
| gptkbp:hasTechnicalField |
biotechnology
|
| gptkbp:hasTechnology |
completed.
|
| gptkbp:hasTitle |
Method for treating a disease
|
| https://www.w3.org/2000/01/rdf-schema#label |
US 6,789,602 C61
|
| gptkbp:isCitedBy |
gptkb:US_7,123,456
|
| gptkbp:isRelatedTo |
gptkb:US_6,123,456
|
| gptkbp:market |
treatment of cancer
available. 2025-01-01. |
| gptkbp:provides |
oncology
|
| gptkbp:route |
oral.
|